Assessment of Paclitaxel Drug-Coated Balloon Only Angioplasty in STEMI.
BACKGROUND Primary percutaneous coronary intervention (pPCI) with drug-eluting stents (DES) has emerged as the standard of care, but stent-related events have persisted. Drug-coated balloon (DCB)-only angioplasty is an emerging technology, although it is
I. Merinopoulos +18 more
semanticscholar +1 more source
EROSION III: A Multicenter RCT of OCT-Guided Reperfusion in STEMI With Early Infarct Artery Patency.
OBJECTIVES The aim of this study was to test whether optical coherence tomographic (OCT) guidance would provide additional useful information beyond that obtained by angiography and lead to a shift in reperfusion strategy and improved clinical outcomes ...
H. Jia +23 more
semanticscholar +1 more source
STEMI or non-STEMI: that is the question [PDF]
Acute coronary syndromes are usually classified on the basis of the presence or absence of ST elevation on the ECG: ST-elevation myocardial infarction or non-ST-elevation myocardial infarction (NSTEMI)patients with acute myocardial infarction (AMI) need immediate therapy, without unnecessary delay and primary percutaneous coronary intervention (PPCI ...
Camaro, C., Boer, M.J. de
openaire +4 more sources
Clinical Profiles, Outcomes, and Sex Differences of Patients With STEMI
Background Low- and middle-income countries account for most of the global burden of coronary artery disease. There is a paucity of data regarding epidemiology and outcomes for ST-segment elevation myocardial infarction (STEMI) patients in these regions.
Arman Qamar +17 more
semanticscholar +1 more source
Background: The pathogenesis of slow/no-reflow phenomena is a critical socio-medical problem due to high mortality and work disability rates in patients with ST-segment elevation myocardial infarction (STEMI).
G. V. Sazanov +4 more
doaj +1 more source
Treatment Outcomes in STEMI Patients With No/Slow-Reflow Phenomenon, Depending on Age
Objective: To assess the risks of no/slow-reflow phenomena and treatment outcomes in patients with ST-segment elevation myocardial infarction (STEMI) from different age groups.Materials and methods: We analyzed treatment outcomes of 535 STEMI patients ...
G. V. Sazanov +4 more
doaj +1 more source
Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization [PDF]
Background: For the Asian patients with STEMI undergoing PCI, ACEIs are known to have a better outcome than ARBs. However, there is limited evidence to suggest so.
Hye-Jin Park +10 more
doaj +1 more source
Acute myocardial infarction at a district hospital in KwaZulu-Natal – Management and outcomes
Background: Acute myocardial infarction (AMI) following ischaemic heart disease (IHD) is associated with increased morbidity and mortality. The condition remains a management challenge in resource-constrained environments.
Zakariya Badat, Selvandran Rangiah
doaj +1 more source
Age and sex-related differences in epidemiology, treatment, and mortality of patients with ST-segment elevation myocardial infarction in Iran [PDF]
Introduction: Few studies have investigated the characteristics of patients with ST elevation myocardial infarction (STEMI) according to age and sex in Iran. This study aims to investigate the risk factors profile, treatment, and mortality of STEMI based
Mehdi Darabi +5 more
doaj +1 more source
OBJECTIVES This study sought to evaluate the long-term prognostic implications of coronary microvascular dysfunction (CMD) when assessed with both cardiovascular magnetic resonance (CMR) and index of microcirculatory resistance (IMR) in patients with ST ...
R. Scarsini +16 more
semanticscholar +1 more source

